# Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects

> **NCT03366389** · — · COMPLETED · sponsor: **Amir Abbasnezhad** · enrollment: 114 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03366389
- **Lead sponsor:** Amir Abbasnezhad
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-07
- **Primary completion:** 2017-09-16
- **Final completion:** 2017-10-20
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366389, "Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03366389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*